Home
Bespak

Bespak Market Share Analysis for May 2026

Bespak can support any strategic option to help customers with low GWP pMDI development and commercialisation, whether that is transition arrangements to support temporary production or long-term outsourcing as an exclusive or second source of supply.

Health > Biotechnology and Pharmaceuticals

Domainbespak.com

Year Founded1959

Employees501 - 1000

Annual Revenue$100M - $200M

Bespak

Bespak (including company regionals)

bespak.com

See more website traffic and engagement information

Bespak Revenue up to May 2026 is 100M - 200M

revenue generated by Bespak top domains

Bespak top domains revenue over 3 years

Revenue for Bespak top domains

bespak.com100M - 200M

See more with Sales Intelligence

Total visits to Bespak's top domains

Understand Bespak market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

bespak.com6K

See more with Sales Intelligence

Avg. visit duration in Bespak's top domains

Analyze Bespak engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

bespak.com00:00:39

See more with Sales Intelligence

Avg. pageviews on Bespak's top domains

See how Bespak keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

bespak.com2.01

See more with Sales Intelligence

Bespak top competitors by domain

Top similar sites in May 2026, ranked by their affinity

hovione.comCompany NameHovioneEmployees1001 - 5000HQJapan, KakudachouAnnual revenue$200M - $500MTotal visits90KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Bespak

These are the website technologies, by industry, used by Bespak top domains

Email Services (4)

Microsoft Exchange Online

Widget (4)

Twemoji

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

More Technologies

12

See all

News & Signals from Bespak

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBespak Limited is developing low carbon pressurised metered dose inhaler.Bespak is manufacturing the first low carbon pressurised metered dose inhaler (pMDI) to be approved and sold anywhere in the world.

NewsChiesi Group partnered with Bespak Limited on Mar 11th '26.Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak's Holmes Chapel site to support the next phase of Chiesi's Carbon Minimal Inhaler (CMI) program.

NewsBespak Limited increases headcount by 150.There were no dissenting votes cast as councillors hailed Bespak's existing output and the potential creation of a further 150 jobs for Holmes Chapel.